The team led by Yu Jintai from Huashan Hospital Affiliated to Fudan University has achieved a landmark breakthrough after five years of painstaking research—for the first time globally, they discovered a new therapeutic target for PD, FAM171A2. This evidence concerns the gene FAM171A2 and Parkinson disease.